Literature DB >> 19933622

Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation.

Soon Ho Yoon1, Jeong Min Lee, Young Ho So, Sung Hyun Hong, Soo Jin Kim, Joon Koo Han, Byung Ihn Choi.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate according to size and degree of cellular differentiation the multiphasic MDCT enhancement pattern of hepatocellular carcinoma (HCC) smaller than 3 cm in diameter in patients with cirrhosis.
MATERIALS AND METHODS: In 155 consecutively registered patients (126 men, 29 women; mean age, 58.4 years), 204 pathologically proven HCCs smaller than 3 cm were detected at multiphasic MDCT. Three radiologists in consensus classified the relative attenuation of the tumors compared with the surrounding liver parenchyma as hyperattenuation, isoattenuation, or hypoattenuation on biphasic (n = 86) and triphasic (n = 69) CT scans.
RESULTS: The prevalent enhancement patterns of HCC differed depending on tumor size. The prevalent pattern of HCC measuring 20-29 mm was arterial hyperattenuation with venous washout (47%, 47/101). The prevalent enhancement patterns of HCC smaller than 10 mm and HCC measuring 10-19 mm were isoattenuation during the arterial and portal venous phases (29%, 6/21) and hyperattenuation and isoattenuation during the arterial and portal venous phases (33%, 27/82). The typical HCC enhancement pattern (arterial hyperattenuation with venous washout) was identified in 48% (67/141) of the moderately and poorly differentiated HCCs and in 13% (8/63) of well-differentiated HCCs.
CONCLUSION: The prevalent enhancement patterns of HCC smaller than 3 cm on multiphasic MDCT scans differed depending on tumor size and cellular differentiation. HCCs smaller than 2 cm and well-differentiated HCCs frequently had atypical enhancement patterns.

Entities:  

Mesh:

Year:  2009        PMID: 19933622     DOI: 10.2214/AJR.08.1818

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  39 in total

1.  Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.

Authors:  J Hwang; S H Kim; M W Lee; J Y Lee
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

2.  Post-transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree.

Authors:  Annarita Pecchi; Giulia Besutti; Mario De Santis; Cinzia Del Giovane; Sofia Nosseir; Giuseppe Tarantino; Fabrizio Di Benedetto; Pietro Torricelli
Journal:  World J Hepatol       Date:  2015-02-27

Review 3.  Magnetic resonance imaging of the cirrhotic liver: An update.

Authors:  Agnes Watanabe; Miguel Ramalho; Mamdoh AlObaidy; Hye Jin Kim; Fernanda G Velloni; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-03-27

Review 4.  Nodule in Liver: Investigations, Differential Diagnosis and Follow-up.

Authors:  Padaki N Rao
Journal:  J Clin Exp Hepatol       Date:  2014-07-23

5.  How often hepatocellular carcinoma has a typical pattern in contrast enhanced ultrasound?

Authors:  Alina Martie; Ioan Sporea; Roxana Sirli; Alina Popescu; Mirela Danila
Journal:  Maedica (Buchar)       Date:  2012-09

6.  Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?

Authors:  Massimo Galia; Adele Taibbi; Daniele Marin; Alessandro Furlan; Marco Dioguardi Burgio; Francesco Agnello; Giuseppe Cabibbo; Bernard E Van Beers; Tommaso Vincenzo Bartolotta; Massimo Midiri; Roberto Lagalla; Giuseppe Brancatelli
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

7.  Contrast-enhanced 3D ultrasonography in minute hepatocellular carcinoma.

Authors:  Masao Ohto; Ryu Ito; Nei Soma; Hiroyuki Fukuda; Yasushi Shinohara; Akio Sakamoto; Fukuo Kondo
Journal:  J Med Ultrason (2001)       Date:  2010-09-16       Impact factor: 1.314

8.  Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience.

Authors:  Yulri Park; Seong Hyun Kim; Seung Hoon Kim; Yong Hwan Jeon; Jongmee Lee; Min Ju Kim; Dongil Choi; Won Jae Lee; Heejung Kim; Ji Hyun Koo; Hyo Keun Lim
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

9.  CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase.

Authors:  Akihiro Nishie; Kengo Yoshimitsu; Daisuke Okamoto; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Daisuke Kakihara; Tomohiro Nakayama; Yukihisa Takayama; Ken Shirabe; Nobuhiro Fujita; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2012-10-17       Impact factor: 2.374

10.  Liver metastasis from hepatoid adenocarcinoma of the stomach mimicking hepatocellular carcinoma: Dynamic computed tomography findings.

Authors:  Yang-Yu Lin; Chien-Ming Chen; Yu-Hsiu Huang; Cheng-Yu Lin; Sung-Yu Chu; Ming-Yi Hsu; Kuang-Tse Pan; Jeng-Hwei Tseng
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.